Bogart Wealth’s Kymera Therapeutics KYMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$447 Buy
+4
New +$458 ﹤0.01% 1856
2026
Q2
– Sell
-5
Closed -$416 – 2056
2026
Q1
$416 Buy
+5
New +$396 ﹤0.01% 1640

Other funds holding KYMR

Bogart Wealth's KYMR Position: Q3 2026 in Review

Bogart Wealth opened a new position in Kymera Therapeutics (KYMR) in Q3 2026: 4 shares worth $447. The stake represents ﹤0.01% of the portfolio and ranks #1856 among its holdings. This is a return to the name: Bogart Wealth previously reported a position in KYMR as recently as Q1 2026.

Bogart Wealth first reported a position in KYMR in Q1 2026 and has held it in 2 quarters since. 299 funds tracked by Wall St. Rank hold KYMR as of Q3 2026.

  • Bogart Wealth held 4 shares of Kymera Therapeutics worth $447 as of Q3 2026.
  • Kymera Therapeutics was a new Bogart Wealth position in Q3 2026.
  • Kymera Therapeutics made up ﹤0.01% of Bogart Wealth's portfolio in Q3 2026, its #1856 holding.
  • Bogart Wealth first reported a position in Kymera Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 299 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q3 2026.

Based on Bogart Wealth's 13F filing for Q3 2026, filed 10 Nov 2026.